Carter Bankshares vs Fulton Financial
CARE and FULT side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CARE and FULT compare
Fulton Financial is the larger company, worth 7.0 times as much as Carter Bankshares ($4.5B against $635M).
On earnings, Carter Bankshares is cheaper: it trades at 4.8× trailing earnings, against 11.2× for Fulton Financial.
Carter Bankshares grew revenue faster over the last twelve months (76.9% versus 10.5% for Fulton Financial).
Fulton Financial keeps more of each dollar of sales as profit, with a net margin of 137% compared with 50.0% at Carter Bankshares.
Both pay dividends: Carter Bankshares yields 1.0% and Fulton Financial 3.2%.
Carter Bankshares scores higher on the StockData Score (15 against 12 for Fulton Financial), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CARE | FULT |
|---|---|---|
| Size and price | ||
| Market cap | $635M | $4.5B |
| Share price | $28.67 | $23.43 |
| Change, 1 year | 63.5% | 31.8% |
| Change, 5 years | 96.4% | 44.6% |
| Beta (5Y) | −0.03 | 0.30 |
| Employees | 687 | 3,400 |
| StockData Score | ||
| Total score | 15 (better) | 12 |
| Valuation score | 6 (better) | 2 |
| Growth score | 1 | 1 |
| Performance score | 3 | 4 (better) |
| Health score | 4 (better) | 2 |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | 4.8× (better) | 11.2× |
| P/S | 2.4× (better) | 15.4× |
| P/B | 1.2× | 1.2× (better) |
| P/FCF | 13.1× | – |
| PEG | – | 1.48 |
| FCF yield | 7.6% | – |
| Fair value | $50.75 | $23.19 |
| Margin of safety | 43.5% (better) | −1.0% |
| Growth | ||
| Revenue growth (TTM) | 76.9% (better) | 10.5% |
| Revenue growth, 5Y average | 2.5% | 4.1% (better) |
| Net income growth (TTM) | 320% (better) | 22.4% |
| EPS growth (TTM) | 335% (better) | 22.2% |
| EPS growth, 5Y average | – | 14.0% |
| Profitability | ||
| Net margin | 50.0% | 137% (better) |
| FCF margin | 18.5% | – |
| Return on equity | 27.9% (better) | 11.1% |
| Financial health | ||
| Altman Z-score | 0.29 (better) | 0.18 |
| Piotroski F-score | 7 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 1.0% | 3.2% (better) |
| Payout ratio | – | 36.8% |
| Years of dividend growth | – | 2 |
| Dividend growth, 5Y average | – | 5.4% |
| Buyback yield | – | 1.9% |
| Shareholder yield | 1.0% | 5.1% (better) |
| Ownership | ||
| Held by institutions | 65.5% | 83.0% |
| Held by insiders | 2.9% | 1.3% |
| Insider net buying, 12 months | −$253K (better) | −$1.5M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 11.2% | – |
Go deeper
- CARE stock overview
- CARE income statement
- CARE valuation and score
- FULT stock overview
- FULT income statement
- FULT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.